JPWO2021099838A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021099838A5 JPWO2021099838A5 JP2022554968A JP2022554968A JPWO2021099838A5 JP WO2021099838 A5 JPWO2021099838 A5 JP WO2021099838A5 JP 2022554968 A JP2022554968 A JP 2022554968A JP 2022554968 A JP2022554968 A JP 2022554968A JP WO2021099838 A5 JPWO2021099838 A5 JP WO2021099838A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- cancer
- alkoxy
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0149117 | 2019-11-19 | ||
| KR1020190149117A KR20210061202A (ko) | 2019-11-19 | 2019-11-19 | 벤조나이트릴이 치환된 축합 피리미딘 유도체 및 그의 의약 용도 |
| PCT/IB2020/000971 WO2021099838A1 (en) | 2019-11-19 | 2020-11-19 | Adenosine receptor antagonist compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505915A JP2023505915A (ja) | 2023-02-13 |
| JPWO2021099838A5 true JPWO2021099838A5 (zh) | 2023-10-05 |
Family
ID=75980093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554968A Pending JP2023505915A (ja) | 2019-11-19 | 2020-11-19 | アデノシン受容体拮抗薬化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230159534A1 (zh) |
| EP (1) | EP4061817A4 (zh) |
| JP (1) | JP2023505915A (zh) |
| KR (2) | KR20210061202A (zh) |
| CN (2) | CN114829363A (zh) |
| AU (2) | AU2020386189B2 (zh) |
| BR (2) | BR122023020015A2 (zh) |
| CA (1) | CA3158731A1 (zh) |
| CL (1) | CL2022001307A1 (zh) |
| IL (1) | IL293107A (zh) |
| MX (1) | MX2022005976A (zh) |
| TW (1) | TW202132304A (zh) |
| WO (3) | WO2021099837A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11806350B2 (en) | 2020-11-19 | 2023-11-07 | Ildong Pharmaceutical Co., Ltd. | Prevention and/or treatment of CNS disorders |
| WO2023201267A1 (en) | 2022-04-13 | 2023-10-19 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA971896B (en) * | 1996-03-26 | 1998-09-07 | Du Pont Merck Pharma | Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives |
| WO1997035846A1 (en) * | 1996-03-26 | 1997-10-02 | Dupont Pharmaceuticals Company | Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
| DK1221444T3 (da) * | 1999-07-02 | 2005-11-14 | Eisai Co Ltd | Kondenserede imidazolforbindelser og lægemidler mod diabetes mellitus |
| GB0100621D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds VI |
| GB0100623D0 (en) * | 2001-01-10 | 2001-02-21 | Vernalis Res Ltd | Chemical compounds IV |
| PL370207A1 (en) | 2001-11-09 | 2005-05-16 | Cv Therapeutics, Inc. | A2b adenosine receptor antagonists |
| CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| GB0906579D0 (en) * | 2009-04-16 | 2009-05-20 | Vernalis R&D Ltd | Pharmaceuticals, compositions and methods of making and using the same |
| WO2011050160A1 (en) * | 2009-10-22 | 2011-04-28 | Biogen Idec Ma Inc. | Pharmaceuticals, compositions and methods of making and using the same |
-
2019
- 2019-11-19 KR KR1020190149117A patent/KR20210061202A/ko unknown
-
2020
- 2020-11-19 US US17/777,881 patent/US20230159534A1/en active Pending
- 2020-11-19 TW TW109140607A patent/TW202132304A/zh unknown
- 2020-11-19 CN CN202080080922.1A patent/CN114829363A/zh active Pending
- 2020-11-19 CN CN202211456336.XA patent/CN116425756A/zh active Pending
- 2020-11-19 CA CA3158731A patent/CA3158731A1/en active Pending
- 2020-11-19 EP EP20890594.3A patent/EP4061817A4/en active Pending
- 2020-11-19 WO PCT/IB2020/000970 patent/WO2021099837A1/en active Application Filing
- 2020-11-19 JP JP2022554968A patent/JP2023505915A/ja active Pending
- 2020-11-19 BR BR122023020015-2A patent/BR122023020015A2/pt unknown
- 2020-11-19 MX MX2022005976A patent/MX2022005976A/es unknown
- 2020-11-19 IL IL293107A patent/IL293107A/en unknown
- 2020-11-19 BR BR112022009487A patent/BR112022009487A2/pt unknown
- 2020-11-19 WO PCT/IB2020/000971 patent/WO2021099838A1/en unknown
- 2020-11-19 KR KR1020227020600A patent/KR20220104760A/ko not_active Application Discontinuation
- 2020-11-19 WO PCT/IB2020/000948 patent/WO2021099832A2/en active Application Filing
- 2020-11-19 AU AU2020386189A patent/AU2020386189B2/en active Active
-
2022
- 2022-05-18 CL CL2022001307A patent/CL2022001307A1/es unknown
-
2023
- 2023-05-09 AU AU2023202886A patent/AU2023202886A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102559851B1 (ko) | 브루톤 티로신 키나제의 이미다조피라진 저해제 | |
| JP6063945B2 (ja) | キナーゼ阻害剤としての４−アルキル置換３，４−ジヒドロピロロ［１，２−ａ］ピラジン−１（２Ｈ）−オン誘導体 | |
| ES2582315T3 (es) | Derivado de ftalazinona-cetona, método de preparación de la misma y uso farmacéutico de la misma | |
| EP2970291B1 (en) | Processes and intermediates for preparing a medicament | |
| WO2017158381A1 (en) | 4,6 dihydropyrrolo [3,4-c] pyrazole-5 (1h)-carbonitrile derivates for trating cancer | |
| AU2023202151A1 (en) | Erbb/btk inhibitors | |
| ES2814289T3 (es) | 1,5-Dihidro-4H-pirazolo[3,4-d]pirimidin-4-onas y 1,5-dihidro-4H-pirazolo[4,3-c]piridin-4-onas como inhibidores de la PDE1 | |
| CA2974788A1 (en) | A 2-pyrimidinyl substituted pyridinyl heterocyclic compound and a pharmaceutical composition comprising the same | |
| WO2004106339A2 (en) | 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF | |
| JP2023503482A (ja) | Ｊａｋ阻害剤としての三複素環式化合物及びその使用 | |
| EP2480549B1 (en) | Fused imidazo[3,2-d]pyrazines as PI3 kinase inhibitors | |
| JPH01226886A (ja) | ピリド〔２，３―ｄ〕ピリミジン誘導体 | |
| JP2018529643A5 (zh) | ||
| AU2023202886A1 (en) | Adenosine receptor antagonist compounds | |
| WO2010098344A1 (ja) | 三環性ピラゾロピリミジン誘導体 | |
| KR20170132278A (ko) | 암 치료에 유용한 1-(사이클로) 알킬 피리딘-2-온의 트리사이클릭 융합 유도체 | |
| WO2021084498A1 (en) | Fluorinated quinoline, quinoxaline and benzo[b][1,4]oxazine derivatives as dihydroorotate dehydrogenase (dhodh) inhibitors for the treatment of cancer, autoimmune and inflammatory diseases | |
| JPWO2021099838A5 (zh) | ||
| JPWO2008050808A1 (ja) | ２−アミノキナゾリン誘導体 | |
| EP4114829A1 (en) | Monoacylglycerol lipase inhibitors | |
| US10889560B2 (en) | 4-amino-2-pyrido-bicyclic pyrimidines and use thereof as topoisomerase II inhibitors | |
| TWI851336B (zh) | 腺苷受體拮抗劑化合物 | |
| TWI850492B (zh) | 腺苷受體拮抗劑化合物 | |
| WO2024023727A1 (en) | Novel acc inhibitors | |
| AU2022412827A1 (en) | Heterocyclic compound having anti-tumor activity and use thereof |